SSR4P1: A Drug Target and Potential Biomarker for Various Diseases

Target Name: SSR4P1

NCBI ID: G728039

SSR4P1

Other Name(s): PRED90 | Signal sequence receptor subunit 4 pseudogene 1 | C21orf122 | PRED57 | signal sequence receptor subunit 4 pseudogene 1

SSR4P1: A Drug Target and Potential Biomarker for Various Diseases

SSR4P1 (PRED90) is a drug target and a potential biomarker for the treatment of various diseases, including cancer. Its unique structure and function make it an attractive target for researchers to study.

SSR4P1 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, and gastrointestinal tract. It is a member of the Src family of proteins, which are known for their ability to initiate and maintain signaling pathways in cells.

One of the most significant functions of SSR4P1 is its role in cell signaling. It plays a key role in the development and maintenance of neural circuits, which are responsible for transmitting information throughout the body. SSR4P1 helps to regulate the formation and maintenance of these circuits, which are critical for proper brain function.

In addition to its role in cell signaling, SSR4P1 has also been shown to play a key role in the regulation of inflammation. It has been shown to help to reduce inflammation in various tissues, which can be a valuable target for the treatment of diseases that are characterized by inflammation, such as cancer.

The structure of SSR4P1 is also of particular interest. It has a unique fold that allows it to interact with a variety of different molecules, including proteins and small molecules. This interaction with other molecules makes it a potentially promising target for the development of new drugs.

One of the most promising aspects of SSR4P1 is its potential as a biomarker. Its expression is often reduced in tissues or cells that are affected by various diseases, which makes it a potential target for the diagnosis and treatment of these diseases. Additionally, its expression is often altered in response to different treatments, which makes it a valuable tool for the study of drug responses.

In conclusion, SSR4P1 is a drug target and a potential biomarker that has the potential to revolutionize the treatment of various diseases. Its unique structure and function make it an attractive target for researchers to study, and its potential as a biomarker makes it an important area of research to explore. Further studies are needed to fully understand its potential and to develop new treatments based on its unique properties.

Protein Name: Signal Sequence Receptor Subunit 4 Pseudogene 1

The "SSR4P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSR4P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets